Belite Bio, Inc (BLTE) stock

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30

$169.96+14.02 (+8.99%)

Close on Nov 12, 2026Market cap $6.69BP/E –Yield –

Belite Bio gross margin

Gross margin is gross profit as a percentage of revenue.

Belite Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?